Search results (41)
« Back to NewsFurther funding secured to hunt out cancer using innovative radiotherapy techniques
8 April 2021
Initial success leads to new award for Oxford researcher pushing forward new cancer-hunting radiotherapy despite lockdown.
Reprogramming tumour cells using an antimalarial drug
17 February 2021
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
Hidden lung damage from COVID-19 revealed in new study
2 December 2020
Research Translational Research
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
Oxfordshire-based SCAN pathway wins BMJ award
9 October 2020
A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.
Tackling the serious side effects of cancer treatment in an ageing population
20 August 2020
Prof. Anne Kiltie and her team discuss their important work into the effects of radiosensitisation on ageing cancer patients with the CRUK Science Blog.
New digital classification method using AI developed for colorectal cancer
22 July 2020
Artificial Intelligence Research Translational Research
Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.
The CNIO creates a collaborative platform to streamline brain metastasis research
8 July 2020
Professor Nicola Sibson has been involved in the CNIO platform to compile a repository for brain metastasis cell lines.
Virtual teaching with AimHi
4 June 2020
One of our scientists, Dr Hannah Bolland, has become a virtual teacher, connecting school students with science.
New Fellow of the Society for Radiological Protection
23 April 2020
Awards & Appointments Research
Many congratulations to Dr Mark Hill, who has become a Fellow of the Society for Radiological Protection (FSRP).
Integrating Cancer Imaging Biomarker Clinical Research Across the UK
26 March 2020
UK National Cancer Imaging Translational Accelerator (NCITA) establishes infrastructure for validation and adoption of cancer imaging biomarkers as decision-making tools in clinical trials and NHS practice. Researchers and medical experts from nine world-leading medical imaging centres across the UK come together to form an integrated infrastructure for standardising and validating cancer imaging biomarkers for clinical use.
Ramandan Group publish original scientific article in Nature Communications
9 March 2020
Group of Professor Kristijan Ramadan has published an original scientific article in Nature Communications today. The article has the first report of a new autophagy receptor TEX264, which may be involved in tumours developing drug resistance.
Breast Cancer Grant for Prof Ramadan
6 February 2020
Congratulations to Prof Kristijan Ramadan who has been awarded a three year research grant from Breast Cancer Now. The grant will support Dr. Abhay Narayan Singh who will explore new ways to use chemotherapy in order to improve the outcomes for women with breast cancer.
World Cancer Day 2020
4 February 2020
Department Public Engagement Research
Tuesday 4 Feb 2020 is World Cancer Day (https://www.worldcancerday.org/). Led by the Union for International Cancer Control, the day aims to raise awareness and education about cancer.
Professor Anna Schuh awarded funding from the NIHR RIGHT programme
4 November 2019
The NIHR has invested £34 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).
A tempting new target for cancer therapy
15 October 2019
DNA Damage & Repair Publication Research
Kristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.
Department of Oncology to collaborate with Crescendo Biologics
20 September 2019
Department Immunology Research
The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
Oxford Open Doors
17 September 2019
On 14 September, the Old Road Campus joined the 2019 Oxford Open Doors event and welcomed the public into our workplace.
Clinical researchers at Oxford University announce new collaboration with Janssen to detect blood cancers sooner
8 August 2019
The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic disease.
The Tarsounas group publish two outstanding papers
25 July 2019
Madalena Tarsounas' group have recently published two new papers in EMBO Molecular Medicine and Nature Communications.